Endothelin-1 plasma levels in patients with both retinitis pigmentosa and flammer syndrome

Klinische Monatsblatter fur Augenheilkunde

Volumn 232, Issue 4, 2015, Pages 514-518

  Todorova, M G ^a   Josifova, T ^a   Konieczka, K ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

endothelin 1 plasma level; Flammer syndrome; ocular blood flow; primary vascular dysregulation; retinitis pigmentosa

Indexed keywords

ENDOTHELIN 1; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; FLAMMER SYNDROME; HUMAN; HYPOTENSION; MALE; NOCICEPTION; PHYSICAL DISEASE BY BODY FUNCTION; RADIOIMMUNOASSAY; RETINITIS PIGMENTOSA; SYNDROME; THIRST; BLOOD; CASE REPORT; COMPARATIVE STUDY; COMPLICATION; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; REPRODUCIBILITY OF RESULTS; RETINITIS PIGMENTOSA; SENSITIVITY AND SPECIFICITY; SYNDROME;

EID: 84928491957     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0035-1545674     Document Type: Article

References (30)

1. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis: 2006; 11 40
2. Grunwald J. E., Maguire A. M., Dupont J. Retinal hemodynamics in retinitis pigmentosa. Am J Ophthalmol: 1996; 122 502 508
3. Cellini M., Lodi R., Possati G. L. et al. Color Doppler ultrasonography in retinitis pigmentosa. Preliminary study. J Fr Ophtalmol: 1997; 20 659 663
4. Akyol N., Kükner S., Celiker U. et al. Decreased retinal blood flow in retinitis pigmentosa. Can J Ophthalmol: 1995; 30 28 32
5. Beutelspacher S. C., Serbecic N., Barash H. et al. Retinal blood flow velocity measured by retinal function imaging in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol: 2011; 249 1855 1858
6. Zhang Y., Harrison J. M., Nateras O. S. et al. Decreased retinal-choroidal blood flow in retinitis pigmentosa as measured by MRI. Doc Ophthalmol: 2013; 126 187 197
7. Falsini B., Anselmi G. M., Marangoni D. et al. Subfoveal choroidal blood flow and central retinal function in retinitis pigmentosa. Invest Ophthalmol Vis Sci: 2011; 52 1064 1069
8. MacCumber M. W., Jampel H. D., Snyder S. H. Ocular effects of the endothelins. Abundant peptides in the eye. Arch Ophthalmol: 1991; 109 705 709
9. Resch H., Karl K., Weigert G. et al. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci: 2009; 50 358 363
10. Cellini M., Santiago L., Versura P. et al. Plasma levels of endothelin-1 in retinitis pigmentosa. Ophthalmologica: 2002; 216 265 268
11. Cellini M., Strobbe E., Gizzi C. et al. ET-1 plasma levels and ocular blood flow in retinitis pigmentosa. Can J Physiol Pharmacol: 2010; 88 630 635
12. Vingolo E. M., Lupo S., Grenga P. L. et al. Endothelin-1 plasma concentrations in patients with retinitis pigmentosa. Regul Pept: 2010; 160 64 67
13. Finzi A., Cellini M., Strobbe E. et al. ET-1 plasma levels, choroidal thickness and multifocal electroretinogram in retinitis pigmentosa. Life Sci: 2014; 10.1016/j.lfs.2014.04.004
14. Ohguro H., Mashima Y., Nakazawa M. Low levels of plasma endothelin-1 in patients with retinitis pigmentosa. Clin Ophthalmol: 2010; 4 569 573
15. Konieczka K., Ritch R., Traverso C. E. et al. Flammer syndrome. EPMA J: 2014; 5 11
16. Flammer J., Konieczka K., Bruno R. M. et al. The eye and the heart. Eur Heart J: 2013; 34 1270 1278
17. Flammer J., Konieczka K., Flammer A. J. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J: 2013; 4 14
18. Flammer J., Mozaffarieh M. Autoregulation, a balancing act between supply and demand. Can J Ophthalmol: 2008; 43 317 321
19. Konieczka K., Flammer A. J., Todorova M. et al. Retinitis pigmentosa and ocular blood flow. EPMA J: 2012; 3 17
20. Moreau P., Takase H., Küng C. F. et al. Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. Hypertension: 1997; 29 763 769
21. Pache M., Schwarz H. A., Kaiser H. J. et al. Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit: 2002; 8 CR616 CR619
22. Pache M., Kaiser H. J., Akhalbedashvili N. et al. Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis. Eur Neurol: 2003; 49 164 168
23. Haufschild T., Shaw S. G., Kaiser H. J. et al. Transient raise of endothelin-1 plasma level and reduction of ocular blood flow in a patient with optic neuritis. Ophthalmologica: 2003; 217 451 453
24. Pache M., Kaiser H. J., Haufschild T. et al. Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients. Am J Ophthalmol: 2002; 133 160 162
25. Pache M., Ochs J., Genth E. et al. Increased plasma endothelin-1 levels in fibromyalgia syndrome. Rheumatology (Oxford): 2003; 42 493 494
26. Flammer J., Kaiser H., Haufschild T. Susac syndrome: a vasospastic disorder? Eur J Ophthalmol: 2001; 11 175 179
27. Berger W., Kloeckener-Gruissem B., Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res: 2010; 29 335 375
28. Marc R. E., Jones B. W., Watt C. B. et al. Neural remodeling in retinal degeneration. Prog Retin Eye Res: 2003; 22 607 655
29. Polak K., Luksch A., Frank B. et al. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res: 2003; 76 633 640
30. Polak K., Petternel V., Luksch A. et al. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects. Invest Ophthalmol Vis Sci: 2001; 42 2949 2956